ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
Washington University School of Medicine
Washington University School of Medicine
Shanghai JMT-Bio Inc.
ImmunityBio, Inc.
AbbVie
OncoC4, Inc.